The cholinergic deficit in Alzheimer's disease

Journal of Clinical Psychiatry

Volumn 59, Issue SUPPL. 13, 1998, Pages 19-22

  Whitehouse, Peter J ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; TACRINE;

ALZHEIMER DISEASE; ANATOMY; ARTICLE; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; DEMENTIA; FOREBRAIN; HUMAN; NEUROCHEMISTRY; NEUROPATHOLOGY; PRIORITY JOURNAL;

AGED; ALZHEIMER DISEASE; BASAL GANGLIA; CELL COUNT; CELL SIZE; CHOLINE O-ACETYLTRANSFERASE; CHOLINERGIC AGENTS; CHOLINERGIC FIBERS; HUMANS; RECEPTORS, CHOLINERGIC; SUBSTANTIA INNOMINATA;

EID: 0031667995     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Whitehouse PJ, Price DL, Clark AW, et al. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 1982;215: 1237-1239
2. Price DL, Whitehouse PJ, Struble RG. Cellular pathology in Alzheimer's and Parkinson's diseases. Trends Neurosci 1986;9:1-5
3. Whitehouse PJ. Theodor Meynert: foreshadowing modern concepts of neuropsychiatric pathophysiology. Neurology 1985;35:389-391
4. Charles V, Mufson EJ, Friden PM, et al. Atrophy of cholinergic basal forebrain neurons following excitotoxic cortical lesions is reversed by intravenous administration of an NGF conjugate. Brain Res 1996;728:193-203
5. Scott SA, Crutcher KA. Nerve growth factor and Alzheimer's disease. Rev Neurosci 1994;5:179-211
6. Crawley JN. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Life Sci 1996;58:2185-2199
7. Schliebs R, Rossner S, Bigl V. Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Prog Brain Res 1996;109:253-264
8. Walsh TJ, Kelly RM, Dougherty KD, et al. Behavioral and neurobiological alterations induced by the immunotoxin 192-IgG-saporin: cholinergic and non-cholinergic effects following i.c.v. injection. Brain Res 1995;702: 233-245
9. Rossner S, Schliebs R, Bigl V. 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res 1995; 696:165-176
10. Arendt T. Impairment in memory function and neurodegenerative changes in the cholinergic basal forebrain system induced by chronic intake of ethanol. J Neural Transm Suppl 1994;44:173-187
11. Cullen KM, Halliday GM. Mechanisms of cell death in cholinergic basal forebrain neurons in chronic alcoholics. Metab Brain Dis 1995;10:81-91
12. Perkins LA, Cain LD. Basic fibroblast growth factor (bFGF) increases the survival of embryonic and postnatal basal forebrain cholinergic neurons in primary culture. Int J Dev Neurosci 1995;13:51-61
13. Kleiner S, Bringmann A. Nucleus basalis magnocellularis and pedunculopontine tegmental nucleus: control of the slow EEG waves in rats. Arch Ital Biol 1996;134:153-167
14. Woolf NJ. The critical role of cholinergic basal forebrain neurons in morphological change and memory encoding: a hypothesis. Neurobiol Learn Mem 1996;6:258-266
15. Whitehouse PJ. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease. In: Yahr MD, Bergmann KJ, eds. Advances in Neurology, vol. 45. New York, NY: Raven Press; 1987;45:393-397
16. Whitehouse PJ, Hedreen JC, White CL III, et al. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 1983;13:243-248
17. Kalaria RN, Homayoun P, Whitehouse P. Nicotinic cholinergic receptors associated with mammalian cerebral vessels. J Auton Nerv Syst 1994;49: 53-57
18. Vaucher E, Hamel E. Cholinergic basal forebrain neurons project to cortical microvessels in the rat: electron microscopic study with anterogradely transported Phaseolus vulgaris leucoagglutinin and choline acetyltransferase immunocytochemistry. J Neurosci 1995;15:7427-7441
19. Cummings JL, Kaufer D. Neuropsychiatric aspects of Alzheimer's disease: the cholinergic hypothesis revisited. Neurology 1996;47:876-883